FI20012082A0 - Biologisesti aktiiviset peptidit hermovauroiden korjaamiseksi - Google Patents
Biologisesti aktiiviset peptidit hermovauroiden korjaamiseksiInfo
- Publication number
- FI20012082A0 FI20012082A0 FI20012082A FI20012082A FI20012082A0 FI 20012082 A0 FI20012082 A0 FI 20012082A0 FI 20012082 A FI20012082 A FI 20012082A FI 20012082 A FI20012082 A FI 20012082A FI 20012082 A0 FI20012082 A0 FI 20012082A0
- Authority
- FI
- Finland
- Prior art keywords
- biologically active
- correction
- active peptides
- nerve damage
- laminin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0815—Tripeptides with the first amino acid being basic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20012082A FI20012082A0 (fi) | 2001-10-26 | 2001-10-26 | Biologisesti aktiiviset peptidit hermovauroiden korjaamiseksi |
EP02770017A EP1438329B1 (de) | 2001-10-26 | 2002-10-25 | Biologisch aktive peptide und deren verwendung zur reparatur verletzter nerven |
DK02770017.8T DK1438329T3 (da) | 2001-10-26 | 2002-10-25 | Biologisk aktive peptider og deres anvendelse til reparation af beskadigede nerver |
DE60238551T DE60238551D1 (de) | 2001-10-26 | 2002-10-25 | Biologisch aktive peptide und deren verwendung zur reparatur verletzter nerven |
AU2002336124A AU2002336124B2 (en) | 2001-10-26 | 2002-10-25 | Biologically active peptides and their use for repairing injured nerves |
PCT/FI2002/000831 WO2003035675A1 (en) | 2001-10-26 | 2002-10-25 | Biologically active peptides and their use for repairing injured nerves |
CA2465245A CA2465245C (en) | 2001-10-26 | 2002-10-25 | Biologically active peptides and their use for repairing injured nerves |
US10/492,850 US20040266991A1 (en) | 2001-10-26 | 2002-10-25 | Biologically active peptides and their use for repairing injured nerves |
JP2003538188A JP4312054B2 (ja) | 2001-10-26 | 2002-10-25 | 生物学的活性ペプチドおよびそれを用いた損傷神経の修復 |
AT02770017T ATE490972T1 (de) | 2001-10-26 | 2002-10-25 | Biologisch aktive peptide und deren verwendung zur reparatur verletzter nerven |
US11/127,206 US7659255B2 (en) | 2001-10-26 | 2005-05-12 | Methods of inhibiting glutamate receptors by administering the tripeptide KDI |
US12/141,129 US7741436B2 (en) | 2001-10-26 | 2008-06-18 | Biologically active peptides and their use for repairing injured nerves |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20012082A FI20012082A0 (fi) | 2001-10-26 | 2001-10-26 | Biologisesti aktiiviset peptidit hermovauroiden korjaamiseksi |
Publications (1)
Publication Number | Publication Date |
---|---|
FI20012082A0 true FI20012082A0 (fi) | 2001-10-26 |
Family
ID=8562134
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI20012082A FI20012082A0 (fi) | 2001-10-26 | 2001-10-26 | Biologisesti aktiiviset peptidit hermovauroiden korjaamiseksi |
Country Status (10)
Country | Link |
---|---|
US (3) | US20040266991A1 (de) |
EP (1) | EP1438329B1 (de) |
JP (1) | JP4312054B2 (de) |
AT (1) | ATE490972T1 (de) |
AU (1) | AU2002336124B2 (de) |
CA (1) | CA2465245C (de) |
DE (1) | DE60238551D1 (de) |
DK (1) | DK1438329T3 (de) |
FI (1) | FI20012082A0 (de) |
WO (1) | WO2003035675A1 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102005029468A1 (de) * | 2005-06-24 | 2006-12-28 | Plt Patent & Licence Trading Ltd. | Verwendung von Inhibitoren der N-Methyltransferasen in der Therapie des Parkinson-Syndroms |
RU2301678C1 (ru) * | 2006-05-30 | 2007-06-27 | Общество С Ограниченной Ответственностью "Сиа Пептайдс" | Пептид, стимулирующий регенерацию нейронов центральной нервной системы, фармацевтическая композиция на его основе и способ ее применения |
BRPI0812357A2 (pt) * | 2007-05-31 | 2015-01-27 | Hertz Corp | Sistema e método para gerar automaticamente um passe de embarque em avião para um viajante retornando um automóvel de aluguel |
US8008253B2 (en) | 2007-07-03 | 2011-08-30 | Andrew Tasker | Treatment for anxiety |
WO2009114539A2 (en) * | 2008-03-10 | 2009-09-17 | University Of Louisville Research Foundation | Neuroprotective integrin-binding peptide and angiopoietin-1 treatments |
GB201700529D0 (en) | 2017-01-12 | 2017-03-01 | Rogers April | Laminin receptor peptide |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT276041B (de) * | 1968-08-16 | 1969-11-10 | Dragoco Gerberding Co Gmbh | Verfahren zur Herstellung eines konzentrierten, praktisch sterilen Rohzwiebelaromas |
US3590722A (en) * | 1969-06-09 | 1971-07-06 | Samuel Leptrone | Flavor injector device |
HU185263B (en) | 1981-06-12 | 1984-12-28 | Richter Gedeon Vegyeszet | Process for producing peptides effective on the immuncontroll analogous with the tp5 |
FI922517A (fi) * | 1992-05-29 | 1993-11-30 | Paeivi Liesi | Nervrepareringsmedel och dess anvaendning |
GB9217316D0 (en) | 1992-08-14 | 1992-09-30 | Ludwig Inst Cancer Res | Schwann cell mitogenic factor,its preparation and use |
GB9324473D0 (en) | 1993-11-29 | 1994-01-12 | Oxford Res Support Co Ltd | Isolation of streptokinase by affinity chromatography |
JPH10507086A (ja) * | 1995-07-26 | 1998-07-14 | フイルメニツヒ ソシエテ アノニム | フレーバー付けられた製品及びその製法 |
US5721256A (en) * | 1997-02-12 | 1998-02-24 | Gpi Nil Holdings, Inc. | Method of using neurotrophic sulfonamide compounds |
WO1998043686A1 (en) | 1997-04-03 | 1998-10-08 | California Institute Of Technology | Enzyme-mediated modification of fibrin for tissue engineering |
US20020168718A1 (en) * | 1997-04-03 | 2002-11-14 | California Institute Of Technology | Enzyme-mediated modification of fibrin for tissue engineering |
US6075119A (en) * | 1997-04-07 | 2000-06-13 | The Rockefeller University | Peptides useful for reducing symptoms of toxic shock syndrome |
IL121191A0 (en) * | 1997-06-29 | 1997-11-20 | Yeda Res & Dev | Synthetic peptides and pharmaceutical compositions comprising them |
JP2003525916A (ja) | 1999-04-22 | 2003-09-02 | エイドゲントシッシュ テクニーシェ ホッシュール チューリッヒ | モディファイドタンパク質マトリクス |
DE20010297U1 (de) | 2000-06-08 | 2000-08-31 | Eth Zuerich Zuerich | Enzymvermittelte Modifizierung von Fibrin zur Gewebemanipulation: Fibrin-Formulierungen mit Peptiden |
-
2001
- 2001-10-26 FI FI20012082A patent/FI20012082A0/fi unknown
-
2002
- 2002-10-25 DK DK02770017.8T patent/DK1438329T3/da active
- 2002-10-25 AU AU2002336124A patent/AU2002336124B2/en not_active Ceased
- 2002-10-25 EP EP02770017A patent/EP1438329B1/de not_active Expired - Lifetime
- 2002-10-25 JP JP2003538188A patent/JP4312054B2/ja not_active Expired - Fee Related
- 2002-10-25 US US10/492,850 patent/US20040266991A1/en not_active Abandoned
- 2002-10-25 CA CA2465245A patent/CA2465245C/en not_active Expired - Fee Related
- 2002-10-25 AT AT02770017T patent/ATE490972T1/de not_active IP Right Cessation
- 2002-10-25 DE DE60238551T patent/DE60238551D1/de not_active Expired - Lifetime
- 2002-10-25 WO PCT/FI2002/000831 patent/WO2003035675A1/en active Application Filing
-
2005
- 2005-05-12 US US11/127,206 patent/US7659255B2/en not_active Expired - Fee Related
-
2008
- 2008-06-18 US US12/141,129 patent/US7741436B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP4312054B2 (ja) | 2009-08-12 |
ATE490972T1 (de) | 2010-12-15 |
US20040266991A1 (en) | 2004-12-30 |
WO2003035675A1 (en) | 2003-05-01 |
JP2005512979A (ja) | 2005-05-12 |
AU2002336124B2 (en) | 2008-07-03 |
US20050288231A1 (en) | 2005-12-29 |
CA2465245A1 (en) | 2003-05-01 |
DE60238551D1 (de) | 2011-01-20 |
US7659255B2 (en) | 2010-02-09 |
EP1438329A1 (de) | 2004-07-21 |
US7741436B2 (en) | 2010-06-22 |
CA2465245C (en) | 2012-09-11 |
DK1438329T3 (da) | 2011-03-28 |
US20080249021A1 (en) | 2008-10-09 |
EP1438329B1 (de) | 2010-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL161591A (en) | Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells | |
CY1111120T1 (el) | Πεπτιδια που παραγονται απο πρωτεϊνες νευρικων ινων και η ιατρικη τους χρηση | |
WO2003008443A3 (en) | Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells | |
HK1077518A1 (en) | Peptides that modulate nerve growth factor (ngf) activity, their compositions and use | |
CA2596597A1 (en) | Method for stimulation collagen synthesis and/or kgf expression | |
DE60040623D1 (de) | Komplementäre, synthetische peptide und ihre nutzung in der ophthalmologie | |
ATE218579T1 (de) | Zusammensetzungen und methoden zur behandlung von infektionen unter verwendung von indolicidin- analogen | |
DE60331546D1 (de) | Verwendung von aspartic proteasen in den bereichen kosmetik und behandlung | |
AU6020099A (en) | Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein | |
ATE427956T1 (de) | Ckrox-peptide und ihre analoge zur behandlung von hautalterung | |
DE60213648D1 (de) | Verwendung von thymulinähnlichen peptiden zur herstellung von schmerzmitteln | |
FI20012082A0 (fi) | Biologisesti aktiiviset peptidit hermovauroiden korjaamiseksi | |
WO2001005810A3 (de) | CYCLISCHE PEPTIDDERIVATE ALS INHIBITOREN DES INTEGRINS αvβ¿6? | |
MXPA04005079A (es) | Variantes del dominio c2 del factor viii. | |
ATE193305T1 (de) | Osteogene wachstums-oligopeptide und diese enthaltende pharmazeutische zusammensetzungen | |
ATE411812T1 (de) | Peptide zur behandlung von infektionen mit dem herpes-virus | |
YU60199A (sh) | Nove soli bpc peptida sa organo-zaštitnom aktivnošću, postupak za njihovo dobijanje i njihova primena u terapiji | |
DE60234843D1 (de) | Modifizierte peptide und deren verwendung zur behandlung von autoimmunkrankheiten | |
WO2003044040A3 (en) | Alpha-fetoprotein peptides and uses thereof | |
PT938329E (pt) | Composicao de tlp imunogenica | |
NO20016341L (no) | Inhibitorer for integrinet <alfa>v<beta>6 | |
MY140828A (en) | Therapeutic uses of tri-, tetra-, penta-, and polypeptides | |
WO2002083729A3 (en) | Polypeptides derived from amyloid precursor peptide (app) and their uses | |
EP1714979A3 (de) | Peptide für die Behandlung von Tumoren und anderen Zuständen, die das entfernen oder zerstören von Zellen erfordern | |
EP1847550A3 (de) | Peptide zur effektiven Behandlung von Tumoren und anderen Bedingungen, die Zellentfernung oder- zerstörung erfordern |